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Abstract
Background: DNA methyltransferase 1 (DNMT1) has been shown to be phosphorylated on multiple serine and
threonine residues, based on cell type and physiological conditions. Although recent studies have suggested that
protein kinase C (PKC) may be involved, the individual contribution of PKC isoforms in their ability to
phosphorylate DNMT1 remains unknown. The PKC family consists of at least 12 isoforms that possess distinct
differences in structure, substrate requirement, expression and localization.
Results: Here we show that PKCa, bI, bII, δ, g, h, ζ and μ preferentially phosphorylate the N-terminal domain of
human DNMT1. No such phosphorylation of DNMT1 was observed with PKCε. Using PKCζ as a prototype model,
we also found that PKC physically interacts with and phosphorylates DNMT1. In vitro phosphorylation assays
conducted with recombinant fragments of DNMT1 showed that PKCζ preferentially phosphorylated the N-terminal
region of DNMT1. The interaction of PKCζ with DNMT1 was confirmed by GST pull-down and co-
immunoprecipitation experiments. Co-localization experiments by fluorescent microscopy further showed that
endogenous PKCζ and DNMT1 were present in the same molecular complex. Endogenous PKCζ activity was also
detected when DNMT1 was immunoprecipitated from HEK-293 cells. Overexpression of both PKCζ and DNMT1 in
HEK-293 cells, but not of either alone, reduced the methylation status of genes distributed across the genome.
Moreover, in vitro phosphorylation of DNMT1 by PKCζ reduced its methytransferase activity.
Conclusions: Our results indicate that phosphorylation of human DNMT1 by PKC is isoform-specific and provides
the first evidence of cooperation between PKCζ and DNMT1 in the control of the DNA methylation patterns of the
genome.
Background
DNA methylation plays a critical role in a large variety of
cellular processes by controlling gene transcription via
gene silencing. Methylation in most animals occurs at the
level of cytosines within the sequence CpG, although low
levels of non-CpG methylation have been reported in
some species. In mammals, there are two classes of DNA
(cytosine-5) methyltransferases, de novo and maintenance
methyltransferases. The de novo methyltransferase in
mammals has two isoforms, DNMT3a and DNMT3b [1].
The maintenance methyltransferase, DNMT1, is the most
prevalent DNA methyltransferase found in cells. DNMT1
has several isoforms, including an oocyte-specific isoform
that lacks the first 118 amino acids [2] and a splice
variant known as DNMT1b [3]. Maintenance methylation
ensures the propagation of tissue-specific methylation
patterns established during mammalian development.
While the DNMT1 enzymes have a preference for hemi-
methylated DNA [4], DNMT3a and DNMT3b act on
either hemimethylated or unmethylated DNA. Thus, the
pattern of mammalian methylation is established and
maintained by a set of at least three different DNA
methyltransferases.
At present, the signaling cascade by which DNA
methylation patterns are imprinted is unclear. Connec-
tions between signaling cascades and epigenetic modifica-
tions have recently been unraveled by studies showing
that the phosphatidylinositol3 - k i n a s e( P I 3 K ) / p r o t e i n
kinase B (PKB) signaling pathway regulates the protein
level of DNMT1, protecting it from degradation via the
ubiquitin-proteasome pathway [5]. The idea that DNMT1
activity could be regulated at the post-translational level
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any medium, provided the original work is properly cited.through phosphorylation by a serine/threonine kinase was
supported by mass spectrometry studies, which reported
phosphorylation sites on the serine and threonine resi-
dues located in the N-terminal domain [6-15]. This
region of DNMT1 fulfills several regulatory functions by
interacting with proteins such as LSH, EZH2, UHRF1,
G9a, DMAP1 (DNMT-associated proteins), HDAC2 (a
histone deacetylase), HP1b, PCNA, and Rb [16-24].
Recently, Hervouet et al. (2010) [25] have demonstrated
that the disruption of DNMT1/PCNA/UHRF1 interac-
tions promote a global DNA hypomethylation in human
gliomas. They also found that such interactions were
regulated by the phosphorylation status of DNMT1 since
phosphorylation of human DNMT1 by Akt and PKC, at
the specific residues serine-127/143 and serine-127
respectively, correlated with global hypomethylation [25].
The protein kinase C (PKC) family consists of ubi-
quitously expressed phospholipid-dependent serine/
threonine kinases, which regulate a large number of
physiological processes, including cell growth and differ-
entiation. Studies on simple organisms have shown that
PKC signaling paradigms are conserved through evolu-
tion from yeast to humans. This conservation under-
scores the importance of this family in cellular signaling
and provides novel insight into PKC function in com-
plex mammalian systems. PKC isoenzymes with differ-
ential cellular distribution, substrate specificities, and
activation responsiveness are divided into three groups:
the conventional PKC isoforms, which are activated by
calcium, diacylglycerol, and phorbol esters (cPKCs; a,
bI, bII and g); the novel PKCs, which are activated by
diacylglycerol but are calcium-insensitive (nPKCs; δ, ε,
h/L (mouse/human) and θ); and the atypical PKCs,
which are calcium- and diacylglycerol-insensitive
(aPKCs; ζ and l/ι (mouse/human)) [26]. Although each
PKC isoform regulates a large number of downstream
targets, individual members of the PKC family are, how-
ever, regulated in different ways, and an increasing num-
ber of studies indicates that they have distinct, and often
opposing, roles [27-29]. In fact, it is now well accepted
that each of the PKC isoforms is unique in its contribu-
tion to specific biological processes [30,31]. Whether all
PKC isoforms can interact with and phosphorylate
DNMT1 remains, however, unknown. Here, we have
examined the ability of PKC isoforms to phosphorylate
the human DNMT1.
Results
In vitro phosphorylation of human DNMT1 by PKC
isoforms
Previous studies have demonstrated that human
DNMT1 is phosphorylated on multiple serine and
threonine amino acid residues [6-15]. Experiments using
broad spectrum of inhibitors have shown that such
phosphorylation on human DNMT1 is dependent on
PKC activity [25]. Since PKC family members have con-
tradictory and tissue specific roles, we have compared
their ability to phosphorylate human DNMT1. Using an
in vitro kinase assay, we found that PKCa, δ, ζ and, to a
lower extent PKCμ, were all able to phosphorylate
recombinant human DNMT1 in a dose-dependent man-
ner (Figure 1A). No such phosphorylation was observed
with PKCε, although this isoform showed similar activity
as compared to other isoforms when tested against a
CREB peptide (Figure 1B). Additional evidence of phos-
phorylation of recombinant full length DNMT1 by a
PKC isoform was demonstrated by gel autoradiography
using PKCζ as a model (Figure 1C).
To further compare the ability of PKC isoforms to
phosphorylate DNMT1, a series of GST fusions covering
the entire length of DNMT1 were challenged with
recombinant PKC isoforms (Figure 2A, B). These frag-
m e n t sh a v ep r e v i o u s l yb e e nu sed to elucidate specific
interaction between DNMT1 and accessory molecules
such as hDNMT3a and hDNMT3b [32], p53 [33] and
G9a [23]. Our results showed that all PKC isoforms pre-
ferentially phosphorylated the N-terminal domain (amino
acids 1-446) of DNMT1 (Figure 2C, D). PKCε was ineffi-
cient in its ability to phosphorylate the N-terminal
domain (Figure 2D). Such inability of PKCε to phosphor-
ylate DNMT1 was not restricted to amino acids 1 to 446
since only negligible phosphorylation of other DNMT1
fragments was observed when compared to the ability of
other isoforms (Figure 3). These results were consistent
with the preferential binding of PKCζ, used here as a pro-
totype model, with the N-terminal domain of DNMT1
(Figure 4A, B). A lower but reproducible binding was
also observed between PKCζ and the C-terminal domains
of DNMT1 encompassing amino acids 1081 to 1409 and
1374 to 1616 (Figure 4C, D).
DNMT1 colocalizes with PKCζ in vivo
Colocalization experiments were carried out by fluores-
cent microscopy in DsRed-DNMT1-transfected HeLa
cells, which were stained with an antibody specific for
the activated form of endogenous PKCζ. Red nuclear
spots appeared in all of the transfectants, which was
consistent with the localization of DNMT1 in the
nucleus (Figure 5B, F). Green nuclear spots identifying
the endogenous activated form of PKCζ were also visible
in the nucleus (Figure 5C, G). Superimposition of GFP
and DsRed-DNMT1 signals resulted in yellow nuclear
spots, demonstrating colocalization of DNMT1 and
PKCζ (Figure 5D, H). Further evidence of an in vivo
physical interaction between DNMT1 and PKC was pro-
vided by immunoprecipitates of c-myc-PKCζ obtained
from nuclear extracts and probed by Western blots with
anti-DNMT1 antibody. Physical interaction between
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Page 2 of 15Figure 1 PKC isoforms phosphorylate human recombinant DNMT1.( A) Quantitative measurements of phosphorylation of 5 nM of DNMT1
in the presence of (g-
32P)ATP for 30 minutes at 30°C with the indicated amounts of activated recombinant human PKCa, δ, ε, μ or ζ. DNMT1
phosphorylation was quantified as the ratio of PKC activity to negative control. Data represent the average of two representative independent
experiments. Bars, S.D. (B) PKC activity of recombinant PKC isoforms against CREB, showing that all isoforms were active. 20 nM of each PKC and
1.5 μM of CREB peptides were used for the assay and were incubated in the presence of (g-
32P)ATP for 30 minutes at 30°C. Bars, S.D. (C)
Autoradiography of a SDS-PAGE showing incorporation (g-
32P)ATP in recombinant human DNMT1 following incubation with different amounts
of human PKCζ.
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Page 3 of 15Figure 2 PKC isoforms preferentially phosphorylate DNMT1 N-terminal domain.( A) Diagram of DNMT1 showing the corresponding
regions of the GST fusion DNMT1 fragments used for phosphorylation assays. Methylation DNA-dependent allosteric activation (MDDAAD),
bromo domain (BD), and nuclear localization sequences (NLS) of DNMT1 are indicated. (B) Coomassie-stained gel representing GST fusion
DNMT1 proteins used for phosphorylation assays. Positions of the fusion fragments are marked with an asterisk. (C) Phosphorylation of GST
fusion DNMT1 fragments following incubation with 20 nM of activated recombinant PKCa, bI, bII, g, δ or h using (g-
32P)ATP. Counts were
obtained following subtraction of the negative control (GST alone). Data are representative of three independent experiments. (D)
Phosphorylation of the GST fusion DNMT1 fragment 1 to 446 following incubation with 20 nM of activated recombinant PKCa, bI, bII, g, δ, ε, h, μ
or ζ using (g-
32P)ATP. Counts were obtained following subtraction of the negative control (GST alone). Data represent the average of three
independent experiments that gave similar results. Bars, S.D.
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Page 4 of 15DNMT1 and PKCζ was demonstrated by the presence
of DNMT1 in PKCζ-c-myc immunoprecipitates (Figure
6A). DNMT1 and PKCζ were not detected in control
immunoprecipitation experiments using cells transfected
with a c-myc expression control vector. Furthermore,
endogenous PKCζ activity was detected in immunopre-
cipitates obtained using anti-DNMT1 antibody, but not
from immunoprecipitates using an isotypic IgG antibody
(Figure 6B). Together, these results confirmed the inter-
action between DNMT1 and PKCζ in HEK-293 cells.
Overexpression of PKCζ and DNMT1 induces DNA
hypomethylation of gene promoters
A recent study has reported that phosphorylation of
DNMT1 is associated with a global DNA hypomethyla-
tion and a poor prognosis in gliomas [25]. To determine
whether interactions between PKCζ and DNMT1 could
also induce genome-wide changes in other cell types,
the DNA methylation status on broad genomic regions
were examined in HEK-293 cells overexpressing PKCζ
and/or DNMT1, or control cells, including cells treated
with the hypomethylating agent 5-aza-2’-deoxycytidine
(5-aza-dC) (Figure 7A). For this purpose, genomic DNA
was immunoprecipitated with an antibody against 5-
methyl-cytosine and hybridized against Affymetrix Pro-
moter 1.0 Tilling Arrays covering 10 to 12.5 kb regions
(2.5 Kb 3’ and 7.5 to 10 Kb) of 25,500 human gene pro-
moters, with an average tilling resolution of 35 nucleo-
tides. Analysis of the signals generated by such arrays
showed an estimated 2,490 methylated regions in HEK-
293 cells. Most of the methylated DNA regions identi-
fied corresponded to CpG islands (see Additional File
1). In fact, of the 2,490 methylated regions, 2,089 were
in CpG islands. Fifteen regions were selected for quanti-
tative analysis of the methylation status by quantitative
PCR (qPCR) based on : 1) their distinct position on the
chromosomes, 2) the presence of a CpG island within
the active region, and 3) their location upstream of a
gene known to be regulated by DNA methylation
(although this criteria was not exclusive) (Table 1).
Methylated DNA query, using specific primers for each
gene showed that most, if not all, of the genes analyzed
had a significant reduction in their methylation status in
cells overexpressing PKCζ and DNMT1, but not in cells
overexpressing either PKCζ or DNMT1 alone (Figure
7B). This reduction in the methylation status was com-
parable to that observed in cells treated with the hypo-
methylating agent 5-aza-dC. This decrease in DNA
methylation status was observed on 15 genes dispersed
on nine different chromosomes. Moreover, all genes,
whether harboring low, medium, or high levels of
methylated regions, were susceptible to the overexpres-
sion of PKCζ and DNMT1. Furthermore, in vitro phos-
phorylation of DNMT1 by PKCζ strongly reduced its
methyltransferase activity (Figure 8), which was consis-
tent with the decrease in DNA methylation observed in
cells overexpressing DNMT1 and PKCζ.
Discussion
In the present report, we have characterized the relation
between PKC isoforms and human DNMT1. More spe-
cifically, we found that: 1) PKCa, bI, bII, δ, g, h, ζ and μ
preferentially phosphorylate the N-terminal domain of
human DNMT1; no such phosphorylation was observed
with PKCε;2 )P K C ζ and DMNT1 physically interact in
vivo in the nucleus of HEK-293 and HeLa cells; 3) PKCζ
activity could be detected in DNMT1 immunoprecipi-
tates of endogenous DNMT1; and 4) overexpression of
PKCζ and DNMT1 in HEK-293 cells induces a decrease
in DNA methylation, consistent with our results show-
ing that phosphorylation of DNMT1 by PKCζ reduces
its methyltransferase activity. Overall, these results pro-
vide novel insights on the ability of PKC isoforms to
play a role in controlling DNA methylation.
Figure 3 PKCε does not phosphorylate individual domains of
DNMT1. Incorporation of (g-
32P)ATP by GST fusion DNMT1
fragments following incubation with 20 nM of activated
recombinant PKCζ, PKCμ or PKCε. Counts were obtained following
subtraction of the negative control (GST alone). Data are
representative of three independent experiments.
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Page 5 of 15In a recent study, the use of broad spectrum inhibitors
have suggested that phosphorylation of DNMT1 likely
involves Akt and PKC [25]. Here, we provide additional
evidence that PKC and DNMT1 physically interact and
regulate DNA methylation. Overall, our experiments have
shown that most PKC isoforms, including PKCa, b, g, δ,
h and ζ, are able to phosphorylate, albeit with different
efficiency, the N-terminal region of human DNMT1. In
fact, the preferential ability of PKC isoforms to interact
with and phosphorylate the region encompassing amino
Figure 4 PKCζ interacts with and phosphorylates DNMT1 fragments.( A) Binding of PKCζ to GST fusion DNMT1 fragments using the pull-
down procedure described in Materials and methods. Input, 10 ng of recombinant PKCζ.( B) Ponceau-stained transferred proteins from pull-
down experiments. Positions of the fusion proteins are marked with an asterisk. (C) Phosphorylation of GST fusion DNMT1 fragments bound and
(D) unbound to beads following incubation with 20 nM of activated recombinant PKCζ using (g-
32P)ATP. Counts were obtained following
subtraction of the negative control (GST alone). Data are representative of three independent experiments. Bars, S.D.
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Page 6 of 15acids 1 to 446 are consistent with previous results show-
ing preferential phosphorylation of Serine127 [25]. Inter-
estingly, PKCε and, to a lesser degree PKCμ,w e r e
inefficient in their ability to phosphorylate DNMT1 or its
N-terminal domain. Such differential phosphorylation by
PKC has often been observed. For example, phosphoryla-
tion of Ser1674 of Cav1.2 a1c, but not Ser1928, is PKC
isoform specific, as only PKCa, bI, bII, g, δ and θ,b u t
not PKCε, ζ and h, phosphorylate this site [34]. Although
it is currently unclear why PKCε is unable to phosphory-
late DNMT1, our observations provide an interesting
experimental model to investigate further the functional
interaction between PKC isoforms and DNMT1.
PKC participates in a multitude of cellular processes,
including differentiation, proliferation, cell cycle progres-
sion and tumorigenesis [30,35]. Increasing evidence has
implicated PKC isoforms in nuclear functions, suggest-
ing that they could represent a pathway to communicate
to the nucleus signals generated at the plasma mem-
brane [36]. For example, in PC12 cells, PKCζ has been
found at the inner nuclear matrix of the nucleus [37],
where DNA replication gene expression and protein
phosphorylation take place [38]. PKCζ has also been
located in the nucleus of rat H9c2 cells during reoxy-
genation after ischemic hypoxia [39]. Here we provide
further evidence of the presence of activated PKCζ in
the nucleus of HeLa cells and of HEK-293 cells, indicat-
ing that translocation of PKCζ into the nucleus is a
common mechanism not restricted to a specific cell
type. Our attempts to demonstrate an interaction
between endogenous DNMT1 and PKCζ by co-immu-
noprecipitation were, however, unsuccessful, most likely
due to low expression level of DNMT1. Using a more
s e n s i t i v ea p p r o a c h ,w ew e r ea b l et os h o wP K C ζ-specific
activity in immunoprecipitates of endogenous DNMT1,
supporting our hypothesis that endogenous DNMT1
and PKCζ could be found in the same complex within
the nucleus. This hypothesis is also supported by our
data showing that flagged DNMT1 interacts with the
endogenous form of PKCζ. Whether nuclear PKCζ
stands in close proximity of DNMT1, ready to act in
proliferative cells, is not known. This could be, however,
a very effective means to rapidly regulate DNMT1 activ-
ity when necessary. A similar paradigm has recently
been proposed from studies on the regulation of
DNMT1 protein stability through the coordinated inter-
action of an array of DNMT1-associated proteins, such
as UHRF1, Tip60 (Tat-interactive protein) and HAUS
(herpes virus-associated ubiquitin specific protease)
[40-42].
Given its preferential ability to phosphorylate the N-
terminal domain of DNMT1, PKCζ may contribute to
the formation of multimolecular complexes copying the
DNA methylation pattern from a parental to a repli-
cated DNA strand. Several proteins have indeed been
reported to interact with DNMT1 via its N-terminal
domain, including PCNA, which recruits DNMT1 at the
mammalian DNA replication forks [20,43-45]. Other
proteins, such as HDAC and DMAP1 [21] initiate the
Figure 5 DNMT1 and PKCζ colocalize in the nucleus of HeLa
cells. HeLa cells are shown with (A), DsRed.DNMT1 (red) (B), GFP-
phosphorylated-PKCζ (green) (C), DsRed.DNMT1 and GFP-
phosphorylated-PKCζ (merged yellow) (D), nucleus (blue) (E), merge
nucleus and DsRed.DNMT1 (F), merge nucleus and GFP-
phosphorylated-PKCζ (G), merge nucleus, DsRed.DNMT1, and GFP-
phosphorylated-PKCζ (H). The construct DsRed.DNMT1 was
transfected in HeLa cells 48 hours before cells fixation and
permeabilization. An anti-phosphorylated-PKCζ rabbit antibody was
used in combination with an anti-rabbit antibody coupled with GFP
to detect endogenous activated form of PKCζ.
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Page 7 of 15formation of DNA replication complexes at the replica-
tion fork to mediate transcriptional repression. DNMT1
has also been associated with methyl-CpG-binding pro-
teins such as MBD2, MBD3 and MeCP2 to maintain
DNA methylation [46,47]. Histone methyltransferases
and HP1 have been recently found to interact with
DNMT1, showing a direct connection between the
enzymes responsible for DNA methylation and histone
methylation [23,24,48]. Furthermore, DNMT1 can
interact with cell cycle regulating proteins such as Rb
and p53 [22,33,49]. It is pertinent to note that PKCζ has
been shown to interact with and to phosphorylate
DNA-bound Sp1, thereby causing the release of the
repressor p107 on the Luteinizing Hormone Receptor
gene promoter in TSA-treated MCF-7 cells [50].
Because Sp1 interacts with HDAC1/2/mSin3A on the
Luteinizing Hormone Receptor gene promoter in both
HeLa and MCF-7 cells [51], and HDAC1/2 binds to
Figure 6 In vivo association between DNMT1 and PKCζ. (A) Co-immunoprecipitation of DNMT1 and PKCζ in nuclear extracts of HEK-293 cells.
The cells were transfected with DNMT1 and PKCζ-c-myc or c-myc for 48 hours and c-myc proteins were purified with immobilized anti-c-myc
beads. Protein complexes were resolved by SDS/PAGE and the presence of PKCζ was demonstrated using an anti-c-myc antibody; DNMT1 and
actin were revealed, respectively, using an anti-DNMT1 and an anti-actin antibody. (B) Detection of endogenous PKCζ activity in DNMT1
immunoprecipitates. Nuclear proteins from HEK-293 cells were incubated with beads prebound to an isotopic IgG antibody or antibodies against
DNMT1 or PKCζ for 4 hours. After several washes, protein-bead complexes were tested for kinase activity using (g-
32P)ATP and PKCζ specific
substrate. Data are representative of three independent experiments. rec. PKCζ, recombinant PKCζ.
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Page 8 of 15Figure 7 Decrease of DNA methylation in HEK-293 cells overexpressing DNMT1 and PKCζ.( A) Western blot analysis showing expression
of PKCζ and DNMT1 in HEK-293 transfected cells used in the analysis of methylated DNA Ip-on-Chip described in Materials and methods. (B)
Histograms representing the methylation status of 15 genes selected from active regions as measured by qPCR using DNA immunoprecipated
with an antibody against 5-methylcytosine. Untr12 was used as a control for a negative region. TRPA1 was used as a positive control. Copy
number values were normalized for primer efficiency by dividing by the values obtained using input DNA and the same primer pairs. Error bars
represent standard deviations calculated from the triplicate determinations. *, P < 0.05; **, P < 0.01.
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Page 9 of 15D N M T 1[ 2 2 ] ,i ti st h u sp o s s i b l et h a tP K C ζ could inter-
act with DNMT1 on the promoter via the Sp1/repressor
complex. Additional studies will be required to test
these possibilities.
Phosphorylation is one of the most common post-
translational modifications occurring in animal cells.
The previous observations that human DNMT1 was
phosphorylated in vivo were indicative that at some
point, DNMT1 was interacting with yet unidentified ser-
ine/threonine kinases. The results from previous mass
spectrometry studies suggested that several phosphoryla-
tion sites were targeted depending on the activation sta-
tus of the cell and/or the cell type [7-15], while Ser154
and Ser714 were shown to be the major phosphorylation
sites in HEK-293 cells [8,12], Ser127, Ser143 and Ser714
in Jurkat cells [13] and Ser143 in lung cancer cells [15].
Although it is unclear at present whether distinct phos-
phorylation sites are targeted by PKC isoforms in differ-
ent cell types, it is likely that Ser127 is preferentially
targeted [25]. Examination of the phosphorylation pro-
file of human DNMT1 reveals, however, the presence of
several alternative phosphosites for PKC isoforms,
including some located in the C-terminal regions of
DNMT1. Future investigations will be necessary to iden-
tify the specific phosphorylation sites in different cell
types and different states.
We found that the overexpression of PKCζ along with
DNMT1 in HEK-293 cells led to a decrease in DNA
methylation and that phosphorylation of DNMT1 by
PKCζ reduced its methyltransferase activity in vitro. Our
preliminary data indicate that these changes in the
methylation status may not, however, be sufficient to
induce or modulate gene expression. For example, no
significant changes in Egr1 mRNA expression were
observed (data not shown). This may not be surprising
because DNA hypomethylation of the promoter does
not always result in increased gene expression. More-
over, in cancer cells, although gene-specific hypomethy-
lation occurs, much of the effect of global DNA
hypomethylation are thought to occur through the acti-
vation of the normally dormant transposons and endo-
genous retroviruses present in the human genome [52].
The fact that overexpression of PKCζ alone was not
Table 1 List of identified genes selected among active regions
Gene GeneBank
Accession no.
Chr
#
Position of active regions Length
(bp)
# of CpG
islands
Gene description
TAS1R3 XM_371210 1 1304459 to 1305587 1,128 1 taste receptor, type 1, member 3
PRKCZ NM_002744 1 2143904 to 2144365 461 0 PKC, zeta
TP73 NM_005427 1 3582480 to 3584936 2,456 1 tumor protein p73
SMYD3 NM_022743 1 242463744 to 242466254 2,510 1 SET and MYND domain containing 3
EGR1 NM_001964 5 137830566 to 137831545 979 1 early growth response 1
TRPA1 NM_007332 8 73149159 to 73150095 936 1 transient receptor potential cation channel,
subfamily A, member 1
B4GALNT4 NM_178537 11 352950 to 353975 1,025 0 beta1,4-N-acetylgalactosaminyltransferases IV
SCT NM_021920 11 617138 to 618042 904 1 secretin
DDIT3 NM_004083 12 56201552 to 56202131 579 0 DNA-damage-inducible transcript 3
MMP17 NM_016155 12 130978656 to 130979436 780 1 matrix metalloproteinase 17
MMP15 NM_002428 16 56617452 to 5661737 285 1 matrix metalloproteinase 15
PRKCA NM_002737 17 61729105 to 61729712 607 1 PKC, alpha
CD7 NM_006137 17 77870114 to 77871217 1,103 1 CD7 antigen (p41)
LGAL7 NM_002307 19 43973066 to 43974116 1,050 1 Galectin-7
MMP11 NM_005940 22 22439567 to 22439961 394 1 matrix metalloproteinase 11
TIMP3 NM_000362 22 31518100 to 31518635 535 0 tissue inhibitor of metalloproteinase 3
Figure 8 Phosphorylation of DNMT1 by PKCζ reduces its
methyltransferase activity. Quantitative measurements of S-
adenosyl-l-(methyl-
3H)methionine integration in a DNA matrix poly
(dI-dC).poly(dI-dC) by 20 nM of recombinant DNMT1 in the
presence 100 ng of recombinant PKCζ incubated with or without
50 μM of ATP for different times. Data are representative of three
independent experiments. Bars, S.D.
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Page 10 of 15sufficient to trigger genome hypomethylation may be
explained, in part, by the presence of excess of PKCζ as
compared to endogenous DNMT1. Unbound PKCζ
might also activate signaling pathways critical for cell
proliferation, differentiation and survival, such as the
ERK/MAPK pathway, thereby providing a counterba-
lance to the negative regulation of DNMT1. It is well
known that PKCζ can activate extracellular signal-regu-
lated kinase/mitogen-activated protein kinase (ERK/
MAPK) pathway in different cell types [39,53,54]. More-
over, it has been shown that inhibition of ERK/MAPK
pathway lead to a decrease in DNA methylation in
colon cancer cells [55].
Our data support the idea that PKC-DNMT1 interac-
tion is important in controlling DNA methylation,
possibly by regulating DNMT1 interaction with other
proteins, such as UHFR1, as recently suggested [25].
This possibility is also supported by data showing that
activation of PKC with phorbol ester in mouse hippo-
campus tissues induced a rapid demethylation of the
reelin promoter [56]. To date, it was believed that such
a role was essentially mediated through the ability of
PKC to down-regulate the DNMT expression at the
mRNA level [56]. Moreover, Sun et al., [5] have also
shown that treatment of HeLa cells with a specific inhi-
bitor of PI3K, which activates PKC, DNMT1 protein
level and genomic content of methylated cytosines were
decreased in a time-dependent manner without affecting
the DNMT1 mRNA level. Whether phosphorylation of
DNMT1 on specific residues was involved in maintain-
ing the functional integrity of the enzyme is in fact a
real possibility because mutations of one of the major
phosphorylation sites of murine DNMT1, Ser515 (pre-
viously referred to as Ser514 by Glickman et al., 1997)
[6], has been shown to significantly reduce the in vitro
enzymatic activity of recombinant DNMT1 [57]. Alter-
natively, phosphorylation of DNMT1 could affect its
structural integrity, therebyr e d u c i n gi t sD N A - b i n d i n g
activity, as shown by Sugiyama et al.v i ain vitro phos-
phorylation of murine DNMT1 by CK1δ [58]. It would
thus be very interesting to determine, for instance,
whether phosphorylation of DNMT1 modulates its abil-
ity to bind specific endogenous DNA sequences, thereby
contributing to the overall genome hypomethylation.
Ideally, however, such experiments will require antibo-
dies that recognize specific PKCζ-mediated phosphory-
lated residues on human DNMT1. Future investigations
will be needed to address this issue.
Conclusions
T h i ss t u d yi st h ef i r s tt oi d e n t i f yP K Cs p e c i f i ci s o f o r m s
involved in the phosphorylation of DNMT1. Indeed, all
PKC isoforms except PKCε, which was very inefficient,
preferentially phosphorylated the N-terminal domain
(amino acids 1 to 446) of DNMT1. Functional implica-
tions of DNMT1 phosphorylation by PKC isoforms have
been highlighted by experiments using PKCζ as a
model, which suggested possible roles in the control of
DNA methylation patterns of the genome, and possibly
in the control of gene expression. Based on the impor-
tance of PKC signaling in a multitude of biological
processes and of a tight regulation of DNA methylation
in normal cells, these findings may provide a novel strat-
egy for cancer therapy.
Methods
Cell lines, reagents and constructs
The HEK-293 and the human HeLa cell lines were
obtained from the American Type Culture Collection
(ATCC) and maintained in Dulbecco’s modified Eagle
complete medium (DMEM) (supplemented with 10%
(v/v) FCS, 2 mmol/L L-glutamine, 10 mmol/L HEPES
buffer). All cell culture products were obtained from
Life Technologies (Burlington, ON, Canada). All other
reagents were purchased from Sigma Chemicals (St.
Louis, MO), unless otherwise indicated. To generate
pEGFP.PKCζ and pMACSK
k.c-myc.PKCζ constructs, the
PKCζ cDNA (kindly provided by Dr. Alex Toker,
Department of Pathology, Harvard Medical School, Bos-
ton, MA, USA) was amplified by PCR using primers
containing internal restriction sites for EcoRI and KpnI
(forward primer: GAATTCATGCCCAGCAGGACC-
GACC; reverse primer: GGTACCCACACGGACTCCT-
CAGC) and XhoI and EcoRI (forward: primer:
CTCGAGATGCCCAGCAGGACCGACC; reverse pri-
mer: GAATTCCACACGGACTCCTCAGC), respec-
tively. The PCR products were then inserted in PCR4.
TOPO (Invitrogen, Burlington, ON, Canada). Following
enzymatic digestion with KpnI/EcoRI or XhoI/EcoRI
(New England Biolabs, Ipswich, MA), the released frag-
ment (2.12 kb) containing the coding region for PKCζ
was gel-purified and ligated into pEGFP.N1 (Clontech
Laboratories, Mountain View, CA) or pMACSK
k.c-myc
(C) (Miltenyi Biotec, Auburn, CA). The resulting
pEGFP.PKCζ and pMACSK
k.c-myc.PKCζ constructs
were validated by sequencing and restriction enzyme
analyses, as well as by Western blotting following transi-
ent transfection in HEK-293 cells. Anti-DNMT1 was
obtained from New England Biolabs and the GFP anti-
body was obtained from Roche Applied Science (Laval,
QC, Canada).
Protein phosphorylation
GST or the fusion proteins bound to glutathione-
Sepharose beads were incubated with 50 μMA T P ,
1 μCi (g-
32P)ATP, kinase buffer (25 mM Tris-HCl (pH
7.5), 5 mM beta-glycerophosphate, 2 mM dithiothreitol
(DTT), 0.1 mM Na3VO4,1 0m MM g C l 2) and 20 nM
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(Cell Signaling Technology, Beverly, MA) at 37°C for 30
minutes. Beads were washed three times, resuspended in
scintillation liquid and the phosphate incorporation was
then measured. For phosphorylation assays using recom-
binant DNMT1 or fusion proteins unbound to glu-
tathione-Sepharose, the reactions were applied on P81
phosphocellulose paper squares (Millipore, Billerica,
MA) and washed three times with 0.75% phosphoric
acid followed by one wash with acetone. Finally, the
paper squares were put in scintillation liquid and the
phosphate incorporation was measured. Otherwise, the
reactions were stopped with the addition of Laemmli buf-
fer and the samples were boiled at 98°C for five minutes.
The reaction products were resolved by SDS-PAGE, and
32P incorporation was analyzed by autoradiography.
GST pull-down assay and Western blot analysis
GST fusion DNMT1 and GST control proteins were
expressed in Escherichia coli BL21 cells, as described
previously [9,10]. Briefly, following induction with 0.3
mM of isopropyl-b-D-thiogalactoside (IPTG) overnight
at 16°C, GST fusion proteins were purified from bacter-
ial crude cell lysates according to the manufacturer’s
instructions (Pfizer-Pharmacia, New York, NY). Binding
assays were performed by pre-incubating the GST or
GST fusion DNMT1 proteins beads with 100 μg/ml
bovine serum albumin (BSA) in a binding buffer (50
mM Tris pH 7.5, 28 μMZ n C l 2 ,1 %T r i t o nX - 1 0 0 ,2 2 0
mM NaCl, 10% glycerol) at 4°C for one hour. The beads
were centrifuged, resuspended in binding buffer and
incubated with 10 ng of recombinant PKCζ at 4°C for
one hour. Beads were then washed three times with
binding buffer containing 500 mM NaCl. The beads
were mixed with 1X SDS-PAGE sample loading buffer
(New England Biolabs) and incubated at 98°C for five
minutes. The protein mixtures were separated on a 4 to
20% polyacrylamide gel (ISS miniplus SupraGel). The
protein bands were blotted onto a nitrocellulose mem-
brane and probed using a PKCζ a n t i b o d y( S a n t aC r u z
Biotechnology Inc., Santa Cruz, CA, USA).
DNA methylation assay
DNA methyltransferase assays were carried out at 37°C
for the indicated time in duplicate with a total volume
of 25 μL of reaction mix, as described previously [4].
Briefly, 20 nM of DNMT1 (New England Biolabs) and
100 ng of PKCζ were incubated with or without 50 μM
of ATP in the presence of 5 μCi of S-adenosyl-l-
(methyl-
3H)methionine (AdoMet) and 50 ng of poly(dI-
dC)·poly(dI-dC) in methyltransferase buffer (50 mM
Tris-HCL, pH 7.8, 1 mM Na2E D T A ,p H8 . 0 ,1m M
DTT, 7 μg/ml phenylmethylsulfonyl fluoride, 5% gly-
cerol) supplemented with 5 μg of phosphatidylserine
and 5 mM MgCl2 to allow PKCζ activity. The reactions
were stopped by transferring the tubes to an ethanol/dry
ice bath, spotted on a DE81 membrane (Millipore) and
processed as described previously [4].
Immunofluorescence analysis
HeLa cells were transfected with 3 μgo fD s R e d -
DNMT1 plasmid using Lipofectamine 2000. After 48
hours, the cells were washed with cold PBS and fixed
with 4% paraformaldehyde in PBS. The cells were then
permeabilized with 0.2% Triton X-100 in PBS. For endo-
genous phosphorylated-PKCζ labeling, the cells were
first incubated overnight at 4°C with a blocking solution
(BSA 5% in PBS-Tween). Antibody against phosphory-
lated-PKCζ (Cell Signaling Technology, Beverly, MA)
was then added and incubated overnight. After several
washes with PBS-Tween, the cells were incubated with
an anti-rabbit secondary antibody coupled with GFP for
1 hour at room temperature and then with Hoechst
33342. Cells were dried, fixed and visualized with a
Zeiss 200 M microscope (Carl Zeiss Microimaging,
Thornwood, NY) with a 63x oil objective lens at 488
nm for GFP-phosphorylated-PKCζ,5 6 8n mf o rD s R e d -
DNMT1 fusion, and 460 nm for nuclear staining with
Hoechst 33342.
Co-immunoprecipitation
HEK-293 cells were seeded in 100 mm dish the day
before transfection at a density of 2 × 10
6 cells/dish.
Cells were transfected with pCDNA4.DNMT1 in combi-
nation with pMACSK
k.c-myc.PKCζ or pMACSK
k.c-myc.
After 48 hours, the cells were harvested and nuclear
proteins were extracted with the CelLytic NuCLEAR
extraction kit. Equal amounts of nuclear lysates (500 μg)
(as determined by the Bradford protein assay) and the
Profound c-myc tag co-IP kit (Pierce, Rockford, IL)
were used to purify c-myc-tagged PKCζ,f o l l o w i n gt h e
manufacturer’s instructions. Briefly, nuclear protein
extracts were incubated with 10 μl of immobilized anti-
c-myc beads with end-over-end mixing for two hours at
4°C. Complexes were washed with TBS several times
and c-myc-tagged proteins were eluted with reducing
sample buffer. Western blot analysis was then per-
formed using an anti-c-myc antibody (Miltenyi Biotec)
to detect c-myc.PKCζ, an anti-DNMT1 antibody to
reveal DNMT1 and an anti-b-actin to detect the loading
control actin.
Western blot analysis
Cells were washed with PBS and homogenized on ice in
lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 25%
glycerol, 1% Triton X-100) supplemented with a cocktail
of protease inhibitors and fresh PMSF (0.5 mM) and
DTT (1 mM). Equal amounts of cell lysates (as
Lavoie et al. BMC Biology 2011, 9:31
http://www.biomedcentral.com/1741-7007/9/31
Page 12 of 15determined by Bio-Rad protein assay) were separated
onto an 8% SDS-PAGE gel and transferred onto nitro-
cellulose membranes (Bio-Rad Laboratories, Mississauga,
ON, Canada). The membranes were blocked with 5%
milk in PBS/0.05% Tween-20 overnight at 4°C and then
probed for two hours at room temperature with primary
antibody diluted 1:5000 in PBS/0.05% Tween-20/5%
milk. After several washes in PBS/0.05% Tween-20,
membranes were probed with a horseradish peroxidase
conjugated anti-mouse or anti-rabbit secondary antibody
(Amersham Biosciences, Baie d’Urfé, QC, Canada)
diluted 1:10,000 in PBS/0.05% Tween-20/5% milk for
one hour at room temperature, followed by several
washes in PBS/0.05% Tween-20. Detection was per-
formed using the enhanced chemiluminescence method
(Amersham Biosciences).
Immunoprecipitation and in vitro kinase assay
HEK-293 cells were harvested at confluency and nuclear
proteins were extracted. Antibodies against DNMT1 or
PKCζ, or an isotypic IgG antibody, prebound to protein
G beads (Invitrogen) were incubated with nuclear pro-
teins in presence of protease inhibitors (at 4°C) on an
orbital shaker for four hours. Proteins bound to beads
were washed three times with phosphate buffer and
resuspended in kinase buffer. The in vitro kinase assay
was carried out as described earlier.
Methylated DNA IP-on-Chip
DNA was isolated by incubating cells overnight at 50°C
in SDS/proteinase K digestion buffer. Lysates were soni-
cated to shear the DNA to an average length of 300 to
500 bp. DNA was extracted with phenol/chloroform fol-
lowed by ethanol precipitation, and then further treated
with RNase and proteinase K and again ethanol-precipi-
tated. Pellets were resuspended and the resulting DNA
was quantified on a Nanodrop spectrophotometer. An
aliquot of DNA (20 μg) was precleared with protein G
agarose beads (Invitrogen). Methylated DNA was
detected using an antibody against 5-methyl-cytosine
(Abcam ab1884, San Diego, CA). After incubation at 4°
C overnight, protein G agarose beads were used to iso-
late the immune complexes. Complexes were washed
and eluted from the beads with SDS buffer. Immunopre-
cipitated DNA was purified by phenol/chloroform
extraction and ethanol precipitation. Quantitative PCR
(qPCR) reactions were carried out in triplicate on speci-
fic genomic regions using SYBR Green Supermix (Bio-
Rad). The resulting signals were normalized for primer
efficiency by carrying out qPCR for each primer pair
using Input DNA. Immunoprecipitated and Input DNAs
were amplified using either random priming or whole-
genome amplification (WGA). For random priming, a
fixed sequence of 17 bases containing 9 random bases at
the 3’ end was used in four linear amplification reac-
tions with Sequenase (USB). Following purification, the
randomly primed ChIP DNA was amplified for 30 cycles
using a fixed sequence primer. For WGA, the Genome-
Plex WGA Kit (Sigma-Aldrich, St.Louis, MO) was used.
The resulting amplified DNA was purified, quantified,
and tested by qPCR at the same genomic regions as
the original immunoprecipitated DNA to assess the
quality of the amplification reactions. The amplified
DNA was digested and labeled using the DNA Term-
inal Labeling Kit (Affymetrix, Fremont, CA), and then
hybridized to Affymetrix GeneChip Human Promoter
1.0R arrays at 45°C overnight. Arrays were washed and
scanned, and the resulting CEL files were analyzed
using the Affymetrix TAS software. Thresholds were
set, and the resulting BED files were analyzed using
Genpathway IP (San Diego, CA, USA) analysis soft-
ware, which provides comprehensive information on
genomic annotation, peak metrics and sample compari-
sons for all peaks (intervals).
Methylated DNA Query
I m m u n o p r e c i p i t a t e dD N Aw a sq u a n t i f i e da ts p e c i f i c
regions using qPCR as described above. Experimental Ct
values were converted to copy numbers detected by
comparison with a DNA standard curve run on the
same PCR plates. Copy number values were then nor-
malized for primer efficiency by dividing by the values
obtained using input DNA and the same primer pairs.
Error bars represent standard deviations calculated from
the triplicate determinations.
Statistical analysis
Student’s t test was used when comparing two means.
The level of significance was determined at P < 0.05.
Additional material
Additional file 1: ChIP-on-Chip results. This Excel file contains the
results of the ChIP-on-chip analysis. The file contains the following three
sheets: the Interval sheet, which lists genomic segments where signals or
P-values are above the threshold, the active regions, which lists genomic
regions containing one or more Intervals, and the gene sheet, which lists
all genes that have Intervals within the chosen GeneMargin. Genes can
have more than one Interval within the GeneMargin. The GeneMargin is
the chosen distance upstream and downstream of a gene that
determines whether an Interval is associated with that gene.
GeneMargins are typically set to 10,000 bp, that is, any Interval within
10,000 bp upstream or downstream of a gene is counted as being
associated with that gene.
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